Editorial Feature

Applying Quantum Computing in Pharmaceutical Research for Faster Drug Discovery

Advancements in quantum computing hold promise for conducting essential medication design procedures, resulting in more effective drug discovery and development.

Applying Quantum Computing in Pharmaceutical Research for Faster Drug Discovery

Image Credit: Alexander Raths/ShutterStock.com

The primary mechanism through which drugs treat diseases is by interacting with molecular targets within the body, thereby changing or regulating their functional states. For instance, certain medications attach to viral proteins, obstructing the virus's entry point into human cells.

Computer-Assisted Drug Discovery

Pharmaceutical companies currently employ a process known as computer-assisted drug discovery (CADD) to process compounds, using methods like Molecular dynamics (MD) simulations and Density functional theory (DFT).

However, the accuracy of fundamental calculations in predicting the behavior of medium-sized pharmacological molecules could take a lifetime. This is because of the severely limited computational power of the classical computers they rely on.

In contemporary drug development processes, computational resources have emerged as crucial elements. Tasks such as molecular modeling and drug screening that predict pharmacodynamics heavily rely on large-scale computations and intricate simulations. These calculations typically demand significant time and access to high-performance computing resources.

Advancements in pharmaceutical science have expanded the scope of diseases and pathological conditions that can now be addressed or mitigated through drug intervention. However, the journey of discovering and developing new drugs is a costly and time-intensive process.

To facilitate the efficient design of effective and safe drugs, scientists require a profound comprehension of how medical compounds interact with their intended biological target.

Although conventional computers have made a substantial contribution to this science, the complexity of computations is greatly increased when simulating complicated and large-scale biomolecular systems, especially those containing quantum phenomena.

This is mainly because quantum mechanical concepts have a significant influence on the behavior of biomolecules. Typical computational methods frequently require approximations, which may reduce accuracy because these systems are complex.

Given this scenario, the question arises: can the increasingly popular quantum computing provide solutions to these challenges in drug design?

By eliminating some of the research-related "dead ends," which add a significant amount of time and expense to the discovery phase, screening periods could be shortened, the number of experimentally based development cycles conducted may decrease, and the range of biological systems accessible to CADD could be expanded with quantum computers.

Quantum Computing

Traditional computers are based on classical physics and use bits as the fundamental unit of data, which can be either a 0 or a 1. On the other hand, quantum computers use quantum bits, or qubits, which can represent and store information in both 0 and 1 states simultaneously thanks to a property called superposition.

In addition to superposition, quantum computers utilize another phenomenon of quantum mechanics called entanglement, where the state of one qubit is dependent on the state of another qubit even, even though they are physically separated. This allows for the creation of complex quantum states that can represent and process large amounts of data concurrently.

Advantages of Quantum Computing in Pharmaceutical Research

Computational methods enabled by quantum computers allow for the effective and direct simulation of quantum processes. This results in the production of more accurate data and insights crucial for drug design, as it enables a more realistic depiction of intermolecular interactions.

Particularly promising is the use of quantum computing to solve complex chemical systems that are difficult for regular computing to handle effectively.

Understanding protein structures is crucial to the efficacy of the molecular docking process in the field of drug creation. Docking is a technique used in molecular modeling that forecasts a molecule's preferred orientation relative to another when a ligand and a target are coupled together to form a stable complex.

Several pathogenic proteins associated with human illnesses pose challenges for traditional small-molecule medications or big macromolecules. As a result, the pharmaceutical industry is becoming more interested in nucleic acid medications, as they offer a chance to overcome the limitations of current targeted therapies and treat conditions that were previously considered "untargetable."

Predicting RNA structures has become a crucial challenge in the search for these nucleic acid drugs, as it can be used to predict how small molecule medications would interact with RNA molecules and identify possible therapeutic targets.

The advantages of quantum computing could improve the efficacy of current CADD technologies by enabling the highly accurate prediction of molecular characteristics. This can have a variety of effects on the development process, including modeling the folding of proteins and the interactions between pharmacological candidates and biologically significant proteins.

In this case, quantum computing may enable researchers to screen computational libraries simultaneously against several potential target structures. The structural flexibility of the target molecule is typically restricted by current techniques due to limited time and computational resources. The likelihood of finding optimal drug candidates may be decreased by these limitations.

In the longer term, quantum computing could enhance hypothesis creation and validation by identifying novel structure-property correlations through machine learning (ML) methods. As quantum computing technology matures, it may enable the production of new types of drug-candidate libraries that incorporate peptides, antibodies, and small compounds.

It may also facilitate a more automated method of finding new drugs, utilizing high-throughput techniques to automatically screen a sizable structural library of physiologically significant targets against compounds that resemble drugs.

Future Outlooks

The implementation of quantum computing technology in medication development portends several changes and breakthroughs due to its rapid continuous development. A more accurate forecast of the safety of pharmacological molecules during the drug design stage can be achieved thanks to quantum computing's ability to model interactions between molecules more realistically.

Quantum computing technology can also handle previously elusive complex biological systems, like protein complexes, and accelerate high-throughput drug screening. It can also foster cross-disciplinary collaboration between physics, computational science, biology, and pharmacology.

More from AZoQuantum: Harnessing Quantum Computing for Breakthroughs in Artificial Intelligence

References and Further Reading

Cox, T. (2023). Researchers demonstrate the power of quantum computing in drug design. [Online] Phys.org. Available at: https://phys.org/news/2023-07-power-quantum-drug.html.

Buntz, B. (2023). Quantum computing promises new frontier in drug discovery and bioinformatics. [Online] Drug Discovery & Development. Available at: https://www.drugdiscoverytrends.com/quantum-computing-drug-discovery/.

Yu, S. (2023). Towards using quantum computing to speed up drug development. [Online] Imperial College London. Available at: https://www.imperial.ac.uk/news/248638/towards-using-quantum-computing-speed-drug/#:~:text=transformations%20and%20advancements.-,Quantum%20computing%20can%20simulate%20interactions%20between%20molecules%20more%20authentically%2C%20enabling,during%20the%20drug%20design%20stage.

Evers, M., Heid, A., Ostoji, I. (2023) Pharma’s digital Rx: Quantum computing in drug research and development. [Online] McKinsey & Company. Available at: https://www.mckinsey.com/industries/life-sciences/our-insights/pharmas-digital-rx-quantum-computing-in-drug-research-and-development.

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

Written by

Ilamaran Sivarajah

Ilamaran Sivarajah is an experimental atomic/molecular/optical physicist by training who works at the interface of quantum technology and business development.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Sivarajah, Ilamaran. (2024, February 21). Applying Quantum Computing in Pharmaceutical Research for Faster Drug Discovery. AZoQuantum. Retrieved on April 14, 2024 from https://www.azoquantum.com/Article.aspx?ArticleID=498.

  • MLA

    Sivarajah, Ilamaran. "Applying Quantum Computing in Pharmaceutical Research for Faster Drug Discovery". AZoQuantum. 14 April 2024. <https://www.azoquantum.com/Article.aspx?ArticleID=498>.

  • Chicago

    Sivarajah, Ilamaran. "Applying Quantum Computing in Pharmaceutical Research for Faster Drug Discovery". AZoQuantum. https://www.azoquantum.com/Article.aspx?ArticleID=498. (accessed April 14, 2024).

  • Harvard

    Sivarajah, Ilamaran. 2024. Applying Quantum Computing in Pharmaceutical Research for Faster Drug Discovery. AZoQuantum, viewed 14 April 2024, https://www.azoquantum.com/Article.aspx?ArticleID=498.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this article?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.